The Centers for Disease Control and Prevention released a report encouraging those at risk for the virus mpox—formerly called monkeypox—and in areas with low vaccination rates to get vaccinated.
May 26, 2023
0
2
Atopic dermatitis (AD) is a chronic inflammatory disease most commonly seen in children and adults. The condition seriously affects patients' quality of life. Its prevalence rate worldwide is 7%–30% in children and 1%–10% ...
May 17, 2023
0
2
For adults with prurigo nodularis (PN), dupilumab, a fully human monoclonal antibody that blocks the shared receptor component for interleukin (IL)-4 and IL-13, demonstrates clinically meaningful and significant improvements ...
May 10, 2023
0
11
A tiny spot on Christy Staats's cheek measured just 0.65 millimeters—or 0.025 inches—and was almost invisible to the human eye. But with help from state-of-the-art non-invasive technology, an OHSU dermatologist and a ...
May 1, 2023
0
4
Skin conditions may be the first sign that a person has a rheumatic disease that will also affect the joints, muscles or ligaments.
Apr 25, 2023
0
36
Atopic dermatitis skin lesions and the lesions produced by infectious complications of the disease look so similar that it makes it impossible for patients to spot the difference and know when to visit their doctor for treatment. ...
Mar 14, 2023
0
5
A patient presenting with painful, swirling skin lesions, chills, and weight loss was found to be suffering from erythema gyratum repens (EGR), a rare and striking skin condition that is associated with underlying malignancy ...
Mar 14, 2023
0
4
A new app developed by scientists at Stanford Medicine and other institutions can detect skin lesions caused by mpox, previously known as monkeypox, in images with an accuracy of 90%, the researchers found in a study. To ...
Mar 3, 2023
0
17
New biomarkers to improve skin cancer detection and avoid delays in treatment are being developed by researchers at the University of South Australia.
Feb 2, 2023
0
2
Researchers at Vanderbilt University Medical Center have developed a new investigational drug that can block inflammatory signaling in a preclinical model of atopic dermatitis—eczema.
Jan 12, 2023
0
10
